Edition:
India

SanBio Co Ltd (4592.T)

4592.T on Tokyo Stock Exchange

3,845JPY
23 Oct 2019
Change (% chg)

-- (--)
Prev Close
¥3,845
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
711,482
52-wk High
¥12,730
52-wk Low
¥2,401

Latest Key Developments (Source: Significant Developments)

SanBio Says U.S. FDA Granted Regenerative Medicine Advanced Therapy Designation For SB623
Thursday, 19 Sep 2019 

Sept 19 (Reuters) - Deutsche Bank AG ::DEUTSCHE BANK ACQUIRES A 5 PERCENT STAKE IN FINTECH DEPOSIT SOLUTIONS.BOTH PARTIES AGREED NOT TO DISCLOSE DETAILS ABOUT THE VOLUME OF THE INVESTMENT.COOPERATION WITH DEPOSIT SOLUTIONS IS ELEMENT OF DEUTSCHE BANK'S PLATFORM STRATEGY.BESIDES DEUTSCHE BANK, NEARLY 100 OTHER BANKS FROM 18 COUNTRIES ARE USING THE DEPOSIT SOLUTIONS PLATFORM.  Full Article

SanBio announces exercise of options
Tuesday, 10 Apr 2018 

April 10(Reuters) - SanBio Co Ltd <4592.T>:Says 4,000 units of its 13th series options were exercised to 400,000 shares of its common stock from April 9 to April 10 .  Full Article

SanBio and Teijin to terminate licensing agreement regarding SB623 for stroke treatment
Wednesday, 14 Feb 2018 

Feb 14 (Reuters) - SanBio Co Ltd <4592.T>:Says co and Teijin Limited would terminate the exclusive licensing agreement signed in 2009, regarding the development and marketing of SB623 for stroke treatment in Japan.  Full Article